A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
PMID:
A 5-hydroxymethylcytosine-based noninvasive model for acute myocardial infarction in type 2 diabetes: implications in cardiovascular outcomes from a 5-year median follow-up study.
PMID:
Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury.
DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA.
Circulation. 2019 Nov 12;140(20):1661-1678. doi: 10.1161/CIRCULATIONAHA.119.040631. Epub 2019 Aug 16.
PMID:31416350
From Atherosclerotic Plaque to Myocardial Infarction-The Leading Cause of Coronary Artery Occlusion.
Młynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M, Rysz J, Franczyk B.
Int J Mol Sci. 2024 Jul 2;25(13):7295. doi: 10.3390/ijms25137295.
PMID:39000400
Outcomes of Acute Myocardial Infarction in Female Patients With Type 1 Diabetes Mellitus.
Santana JC, Dangl M, Albosta M, Colombo R.
Am J Cardiol. 2023 Nov 1;206:12-13. doi: 10.1016/j.amjcard.2023.08.041. Epub 2023 Sep 5.
PMID:37677877
Presenting Symptoms in Men and Women Diagnosed With Myocardial Infarction Using Sex-Specific Criteria.
Ferry AV, Anand A, Strachan FE, Mooney L, Stewart SD, Marshall L, Chapman AR, Lee KK, Jones S, Orme K, Shah ASV, Mills NL.
J Am Heart Assoc. 2019 Sep 3;8(17):e012307. doi: 10.1161/JAHA.119.012307. Epub 2019 Aug 20.
PMID:31431112
Sex-specific AKI risk in acute myocardial infarction patients with type 2 diabetes mellitus.
Huang X, Wang H, Yuan W.
Front Endocrinol (Lausanne). 2025 Sep 30;16:1654587. doi: 10.3389/fendo.2025.1654587. eCollection 2025.
PMID:41098588
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia.